# Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer

> **NCT00030420** · PHASE2 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 24 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00030420
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2004-05
- **Final completion:** 2008-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030420, "Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00030420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*